Point of Care Glucose Testing Market Size, Share, Analysis, Trends, Growth, 2032

Point of Care Glucose Testing Industry Prospective:

The global point of care glucose testing market size was evaluated at $4.2 billion in 2023 and is slated to hit $6.4 billion by the end of 2032, with a CAGR of nearly 5.1% between 2024 and 2032.

Request Free Sample

Point of Care Glucose Testing Market: Overview

Point-of-care glucose testing is a procedure for measuring levels of glucose in the blood. It is used to monitor the proportion of sugar in the blood of diabetic people. The method is beneficial in hospital settings, where it can help healthcare service providers make quick decisions pertaining to patient treatment related to regulating blood glucose levels.

Key Insights

• As per the analysis shared by our research analyst, the global point of care glucose testing market is projected to expand annually at the annual growth rate of around 5.1% over the forecast timespan (2024-2032)
• In terms of revenue, the global point of care glucose testing market size was evaluated at nearly $4.2 billion in 2023 and is expected to reach $6.4 billion by 2032.
• The global point of care glucose testing market is anticipated to grow rapidly over the forecast timeline owing to a surge in the number of diabetics and the aging population prone to this disorder.
• In terms of product, the continuous glucose monitors segment is slated to dominate the segmental space over forecast period.
• Based on end-user, the home use segment is predicted to lead the global industry surge in the ensuing years.
• Region-wise, the Asia-Pacific point of care glucose testing industry is projected to register the fastest CAGR during the assessment timespan.

Point of Care Glucose Testing Market: Growth Factors

An increment number of individuals suffering from diabetes to prop up the global market trends

A surge in the number of diabetics and the aging populace prone to this disorder can promote the growth of the global point of care glucose testing market. Additionally, a rise in the need to constantly monitor the glucose levels of critically ill patients in hospitals is likely to augment the global market landscape.

Reportedly, POC glucose testing assists healthcare service providers in quickly analyzing glucose levels in the blood of patients who experience glycemia changes as a result of stress and illness. High focus on patient empowerment and demand for accurate, cost-efficient, and user-friendly POC testing devices will scale up the expansion of the global market.

Point of Care Glucose Testing Market: Restraints

Escalating device costs can restrict the growth of the global industry over the forecast period

Surging device costs and a lack of know-how about the benefits offered by POC glucose testing devices are some of the key hindrances to the global point of care glucose testing industry. Additionally, issues pertaining to the accuracy of POC glucose tests can lead to inappropriate diagnosis and treatment, thereby hindering product demand in the healthcare sector.

Point of Care Glucose Testing Market: Opportunities

Rising purchase of various medical devices for home testing purposes to define the growth of the global market

Growing preference for home testing by diabetics is predicted to create new growth avenues for the global point of care glucose testing market. Integrating POC testing equipment with telemedicine is likely to amplify the growth of the market globally. Escalating focus of healthcare service providers on the application of precision medicine for treating diabetics is expected to foster the expansion of the market globally.

Point of Care Glucose Testing Market: Challenges

Less access to efficient workforce can hinder the expansion of the global industry

Lack of availability of skilled personnel and the need to comply with stringent laws related to the use of point of care glucose testing devices is expected to challenge the global point of care glucose testing industry progression. Compensation issues for using point of care glucose testing devices faced by patients with few of the insurance firms not providing insurance coverage for POC testing equipment can deter the global industry expansion.

Point of Care Glucose Testing Market: Report Scope

Point of Care Glucose Testing Market: Segmentation

The global point of care glucose testing market is divided into product, end-user, and region.                                                    

In terms of product, the point of care glucose testing market across the globe is segmented into blood glucose meters, continuous glucose monitors, and lancing devices & strips segments. The continuous glucose monitors segment is likely to be the leading segment during the forecast timeline. The rapid growth of this segment can be owing to high accuracy of the product and availability of continuous glucose monitors in various sizes. Focus on patient empowerment will drive the segmental surge.

On the basis of end-user, the global point of care glucose testing industry is bifurcated into home use, ambulatory care settings, hospitals & settings, long-term care facilities, pharmacies, and hospitals & clinics segments. Furthermore, the home use segment is likely to dominate the growth of the global industry in the coming eight years. The key factors driving the segmental elevation can be attributed to numerous factors, such as the surging occurrence of chronic disorders, technological breakthroughs, and patients’ focus on effectively managing health through point-of-care glucose testing devices.

Point of Care Glucose Testing Market: Regional Insights

North America is projected to maintain a leading position in the global market over the expected timeline

North America, which contributed approximately 54% of the global point of care glucose testing market earnings in 2023, is anticipated to maintain a dominant position in the coming few years.

Apparently, the arithmetic progression of the market in North America over the forecast timeframe can be due to a rise in the use of new diagnostic methods and the presence of strong healthcare infrastructure facilities in countries such as the U.S. Presence of key product manufacturers along with huge investments in research activities is likely to foster the regional market growth.

The Asia-Pacific point of care glucose testing industry is set to record the highest CAGR in the forecast period. The industry expansion in the region can be credited to the surging occurrence of diabetes in countries such as India and China. Moreover, technological breakthroughs in glucose testing tools, such as the launch of non-invasive & user-friendly equipment, will further boost the industry expansion in the region.

Point of Care Glucose Testing Market: Competitive Space

The global point of care glucose testing market profiles key players such as:

• PTS Diagnostics
• Abbott Laboratories
• Ascensia Diabetes Care Holdings AG
• Acon Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Dexcom Inc.
• Medtronic plc
• LifeScan Inc.
• Becton
• Dickinson and Company
• Nova Biomedical Corporation
• ARKRAY Inc.
• Trividia Health Inc.
• Ypsomed Holding AG
• Nipro Diagnostics Inc.
• Sanofi S.A.

The global point of care glucose testing market is segmented as follows:

By Product

• Blood Glucose Meters
• Continuous Glucose Monitors
• Lancing Devices & Strips

By End-User

• Home Use
• Ambulatory Care Settings
• Hospitals & Settings
• Long-Term Care Facilities
• Pharmacies
• Hospitals & Clinics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa